VC
GILD icon

Veracity Capital’s Gilead Sciences GILD Stock Holding History

Veracity Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-31,400
Closed -$2.42M – 256
2020
Q2 		$2.42M Sell
31,400
-8,800
-22% -$674K 0.68% 39
2020
Q1 		$3M Buy
+40,200
New +$2.78M 0.87% 25

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Veracity Capital's GILD Position: Q2 2026 in Review

Veracity Capital increased its Gilead Sciences (GILD) stake by 10% in Q2 2026, buying an estimated $93.7K and bringing the position to 7,784 shares worth $983K. The position accounts for 0.27% of the portfolio, ranked #76.

Veracity Capital first reported a position in GILD in Q1 2020 and has held it in 14 quarters since. The position peaked at $986K in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Veracity Capital held 7,784 shares of Gilead Sciences worth $983K as of Q2 2026.
  • Veracity Capital bought 711 Gilead Sciences shares in Q2 2026, an estimated $93.7K.
  • Gilead Sciences made up 0.27% of Veracity Capital's portfolio in Q2 2026, its #76 holding.
  • Veracity Capital first reported a position in Gilead Sciences in Q1 2020 and has held it in 14 quarters since.
  • Veracity Capital's Gilead Sciences position peaked at $986K in Q1 2026.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Veracity Capital's 13F filing for Q2 2026, filed 13 Jul 2026.